MAGED1 and myeloid sarcoma: Although counterintuitive, hypomethylation of axon guidance pathways in those with severe MS may represent an adaptive mechanism aimed at countering MS-associated neurodegeneration, where neurodegenerative pathways regulated via the p75 neurotrophin receptor, and NRAGE-mediated cell death pathways were also identified as differentially methylated in our study.